Citius Pharmaceuticals
Stock Forecast, Prediction & Price Target

Citius Pharmaceuticals Financial Estimates

Citius Pharmaceuticals Revenue Estimates

Citius Pharmaceuticals EBITDA Estimates

Citius Pharmaceuticals Earnings per Share Estimates

Passed Analyst forecast
Metric 9/30/2022 9/30/2023 9/30/2024 9/30/2026 9/30/2027 9/30/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $200.00M
Low: $180.67M
High: $219.33M
avg. 0%
Avg: $336.26M
Low: $303.75M
High: $368.76M
avg. 68.12%
Avg: $438.05M
Low: $395.71M
High: $480.40M
avg. 30.27%
Net Income
 
% change YoY
$-33.64M
 
N/A
$-32.54M
 
3.26%
$-39.42M
 
-21.15%
Avg: $97.43M
Low: $63.49M
High: $81.74M
avg. 347.12%
Avg: $143.72M
Low: $125.67M
High: $161.79M
avg. 47.52%
Avg: $204.24M
Low: $178.58M
High: $229.91M
avg. 42.10%
EBITDA
 
% change YoY
$-32.88M
 
N/A
$-36.72M
 
-11.69%
$0
 
100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.23
 
N/A
-$0.23
 
0%
$0
 
100%
Avg: $0.48
Low: $0.42
High: $0.54
avg. 0%
Avg: $0.95
Low: $0.83
High: $1.07
avg. 97.91%
Avg: $1.35
Low: $1.18
High: $1.52
avg. 42.10%
Operating Expenses
 
% change YoY
$33.31M
 
N/A
$36.73M
 
10.25%
$41.99M
 
14.32%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Citius Pharmaceuticals stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 145.58% in 2026-2028.

We have gathered data from 1 analysts. Their low estimate is 63.49M, average is 97.43M and high is 81.74M.

What is Citius Pharmaceuticals stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 32.79% in 2026-2028.

We have gathered data from 1 analysts. Their low revenue estimate is $180.67M, average is $200.00M and high is $219.33M.

What is Citius Pharmaceuticals stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 46.67% in 2026-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is $0.42, average is $0.48 and high is $0.54.